China’s Dezhan launches 2 products
China’s Dezhan Health said it launched a hemp cosmetics series and a hemp-based drink on the domestic market on a trial basis, and announced a series of asset acquisitions in …
China’s Dezhan Health said it launched a hemp cosmetics series and a hemp-based drink on the domestic market on a trial basis, and announced a series of asset acquisitions in …
[Third & last in a series] As Chinese planners see the future, the nation will transition from a global factory for cheap, low-quality goods up the value chain to offer …
The Chinese Strategy: Planning a roadmap to hemp’s future Read More »
[Second in a series] As China sharply turns renewed attention to the potential of industrial hemp, it is quickly developing the financial resources and infrastructure that will solidify and strengthen …
The Chinese Strategy: ‘Add more fuel’ to the hemp juggernaut Read More »
Development of industrial hemp technology is among cooperative initiatives planned between Israel and the Chinese province of Yunnan, representatives of both sides said during the 6th China Yunnan-Israel Innovation Cooperation …
[First in a series] The recent report that the Institute of Hemp at the Chinese Academy of Agricultural Sciences has developed a suite of new hemp cultivars for CBD is …
Pushing the outer limits of what can be done with the plant Read More »
China’s Shenzhen Hanyu Pharmaceuticals launched the first products in its Hanyu Original skincare line. Yu Pinxiang, Hanyu’s CEO, said the company plans more products under the brand. He also reported …
The board of China’s Renhe Pharmaceuticals Co., Ltd. agreed to develop a broad-based industrial hemp project and three other initiatives in the medical sector. Projects approved by the board in …
The board chairman of a Chinese pharmaceutical company could be facing fines as the result of an insider trading investigation. Hunan Fangsheng Pharmaceutical Co., Ltd issued a statement last week …
Chinese pharma company executive targeted in stock probe Read More »
Chinese conglomerate Chengzhi Co. Ltd. said its subsidiary Chengzhi Hanmeng has obtained a license to plant hemp in Yunnan Province. The company said the license will help to strengthen Chengzhi Hanmeng’s industrial …
Chinese pharma giant Tasly Holding Group Co., Ltd. has invested 500 million yuan (~€64 million/~$75 million) in Puyuan Miaosheng Group (PMG), a biotech company. The strategic alliance aims to advance …
Chinese pharma giant invests €64 million in hemp company Read More »